Abstract: There is provided an invention relating to compositions and therapeutic uses of atomic quantum clusters (AQCs), in particular compositions consisting essentially of AQCs comprising 5 zero-valent transition metal atoms for use in the treatment of a cell proliferative disorder.
Type:
Application
Filed:
September 25, 2019
Publication date:
February 3, 2022
Applicants:
NANOGAP SUB-NM-POWDER, S.A., UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
Inventors:
David BUCETA FERNÁNDEZ, Fernando DOMÍNGUEZ PUENTE, Manuel Arturo LÓPEZ QUINTELA
Abstract: The present invention refers to process for oxidation of organosulfur compounds comprising metal AQCs having between 5 and 13 metal atoms as catalyst. Additionally, the present invention refers to the use of the metal AQCs having between 5 and 13 metal atoms as catalyst in the oxidation of organosulfur compounds and to a chemical composition comprising organosulfur compounds and metal AQCs having between 5 and 13 metal atoms.
Type:
Grant
Filed:
July 20, 2018
Date of Patent:
October 19, 2021
Assignees:
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA, NANOGAP SUB-NM-POWDER, S.A.
Inventors:
Manuel Arturo López Quintela, David Buceta Fernández
Abstract: The present invention relates to nanocompounds comprising a charge-transfer complex of at least two different size metal atomic quantum clusters (AQCs) and the use thereof as luminescent nanocompounds, particularly for the use thereof as fluorescent nanocompounds; as well as the method for obtaining and detecting them.
Abstract: The present invention relates to nanocompounds comprising a charge-transfer complex of at least two different size metal atomic quantum clusters (AQCs) and the use thereof as luminescent nanocompounds, particularly for the use thereof as fluorescent nanocompounds; as well as the method for obtaining and detecting them.